ATRA
Price
$6.16
Change
-$0.74 (-10.72%)
Updated
Mar 10 closing price
Capitalization
39.74M
FOLD
Price
$8.63
Change
-$0.23 (-2.60%)
Updated
Mar 10 closing price
Capitalization
2.72B
57 days until earnings call
Ad is loading...

ATRA vs FOLD

Header iconATRA vs FOLD Comparison
Open Charts ATRA vs FOLDBanner chart's image
Atara Biotherapeutics
Price$6.16
Change-$0.74 (-10.72%)
Volume$144.09K
Capitalization39.74M
Amicus Therapeutics
Price$8.63
Change-$0.23 (-2.60%)
Volume$2.88M
Capitalization2.72B
ATRA vs FOLD Comparison Chart
Loading...
ATRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FOLD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATRA vs. FOLD commentary
Mar 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATRA is a Buy and FOLD is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Mar 11, 2025
Stock price -- (ATRA: $6.12 vs. FOLD: $8.63)
Brand notoriety: ATRA and FOLD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATRA: 57% vs. FOLD: 123%
Market capitalization -- ATRA: $39.74M vs. FOLD: $2.72B
ATRA [@Biotechnology] is valued at $39.74M. FOLD’s [@Biotechnology] market capitalization is $2.72B. The market cap for tickers in the [@Biotechnology] industry ranges from $383.59B to $0. The average market capitalization across the [@Biotechnology] industry is $2.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATRA’s FA Score shows that 0 FA rating(s) are green whileFOLD’s FA Score has 0 green FA rating(s).

  • ATRA’s FA Score: 0 green, 5 red.
  • FOLD’s FA Score: 0 green, 5 red.
According to our system of comparison, both ATRA and FOLD are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATRA’s TA Score shows that 5 TA indicator(s) are bullish while FOLD’s TA Score has 5 bullish TA indicator(s).

  • ATRA’s TA Score: 5 bullish, 4 bearish.
  • FOLD’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, ATRA is a better buy in the short-term than FOLD.

Price Growth

ATRA (@Biotechnology) experienced а -12.57% price change this week, while FOLD (@Biotechnology) price change was -5.48% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.04%. For the same industry, the average monthly price growth was -8.82%, and the average quarterly price growth was -8.10%.

Reported Earning Dates

ATRA is expected to report earnings on Aug 12, 2024.

FOLD is expected to report earnings on May 07, 2025.

Industries' Descriptions

@Biotechnology (-0.04% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
FOLD($2.72B) has a higher market cap than ATRA($39.7M). FOLD YTD gains are higher at: -8.386 vs. ATRA (-54.020). FOLD has higher annual earnings (EBITDA): -9.2M vs. ATRA (-123.21M). FOLD has more cash in the bank: 250M vs. ATRA (67.2M). ATRA has less debt than FOLD: ATRA (49.9M) vs FOLD (445M). FOLD has higher revenues than ATRA: FOLD (494M) vs ATRA (100M).
ATRAFOLDATRA / FOLD
Capitalization39.7M2.72B1%
EBITDA-123.21M-9.2M1,340%
Gain YTD-54.020-8.386644%
P/E RatioN/AN/A-
Revenue100M494M20%
Total Cash67.2M250M27%
Total Debt49.9M445M11%
FUNDAMENTALS RATINGS
ATRA vs FOLD: Fundamental Ratings
ATRA
FOLD
OUTLOOK RATING
1..100
765
VALUATION
overvalued / fair valued / undervalued
1..100
78
Overvalued
75
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10095
PRICE GROWTH RATING
1..100
9396
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

FOLD's Valuation (75) in the Biotechnology industry is in the same range as ATRA (78). This means that FOLD’s stock grew similarly to ATRA’s over the last 12 months.

FOLD's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as ATRA (100). This means that FOLD’s stock grew similarly to ATRA’s over the last 12 months.

FOLD's SMR Rating (95) in the Biotechnology industry is in the same range as ATRA (100). This means that FOLD’s stock grew similarly to ATRA’s over the last 12 months.

ATRA's Price Growth Rating (93) in the Biotechnology industry is in the same range as FOLD (96). This means that ATRA’s stock grew similarly to FOLD’s over the last 12 months.

ATRA's P/E Growth Rating (100) in the Biotechnology industry is in the same range as FOLD (100). This means that ATRA’s stock grew similarly to FOLD’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ATRAFOLD
RSI
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
72%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
71%
Momentum
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
81%
MACD
ODDS (%)
Bullish Trend 1 day ago
89%
Bearish Trend 1 day ago
75%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
78%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
76%
Advances
ODDS (%)
Bullish Trend 6 days ago
83%
Bullish Trend 11 days ago
72%
Declines
ODDS (%)
Bearish Trend 18 days ago
87%
Bearish Trend 1 day ago
76%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
74%
Aroon
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
88%
View a ticker or compare two or three
Ad is loading...
ATRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FOLD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FTEIX12.44N/A
N/A
Fidelity Advisor Total Intl Equity I
ISCGX5.60N/A
N/A
Transamerica Small Cap Growth I
EMGDX27.56N/A
N/A
Allspring Emerging Markets Equity R6
GGCPX13.86N/A
N/A
Goldman Sachs International T/M Eq P
CIBFX71.96-0.72
-0.99%
American Funds Capital Income Bldr F1

ATRA and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATRA has been closely correlated with IKNA. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if ATRA jumps, then IKNA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATRA
1D Price
Change %
ATRA100%
-11.30%
IKNA - ATRA
72%
Closely correlated
-2.08%
AMLX - ATRA
55%
Loosely correlated
-9.82%
ABCZF - ATRA
53%
Loosely correlated
N/A
RAPT - ATRA
37%
Loosely correlated
-5.31%
PHAT - ATRA
36%
Loosely correlated
-13.24%
More

FOLD and

Correlation & Price change

A.I.dvisor indicates that over the last year, FOLD has been loosely correlated with VCYT. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if FOLD jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FOLD
1D Price
Change %
FOLD100%
-2.60%
VCYT - FOLD
43%
Loosely correlated
-5.09%
SRPT - FOLD
42%
Loosely correlated
-3.24%
AXON - FOLD
39%
Loosely correlated
-2.08%
MDXG - FOLD
38%
Loosely correlated
-1.27%
DNLI - FOLD
36%
Loosely correlated
-10.43%
More